20132 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
#602Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
#603Antidepressant oral pharmaceutical compositions
#604HMG-CoA reductase inhibitor extended release formulation
#605HMG-CoA reductase inhibitor extended release formulation
#606Coating composition
#607Stabilizing formulations
#608Dosage forms of risedronate
#609Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form
#610Sustained release pharmaceutical preparations and methods for producing the same
#611Liposome drug delivery
#612Pharmaceutical formulations of amyloid inhibiting compounds
#613Edible holographic products, particularly pharmaceuticals and methods and apparatus for producing same
#614Stabilized leukotriene B(LTB) agent pharmaceutical formulation
#615Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof
#616Pharmaceutical compositions containing venlafaxine
#617Stable pharmaceutical formulations of benzimidazole compounds
#618Pharmaceutical tablets containing tibolone and a coating
#619Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
#620Controlled release composition using transition coating, and method of preparing same
#621Method of treating attention deficit disorders with d-threo methylphenidate
#622Composition comprising a benzimidazole and process for its manufacture
#623Pharmaceutical dose form with a patterned coating and method of making the same
#624Solid dosage form for acid-labile active ingredient
#625Pravastatin pharmaceutical formulations and methods of their use
#626Sustained release dosage forms
#627Sustained release neutralized divalproex sodium
#628Sugar coatings and methods therefor
#629Modified release dosage forms
#630Coated tablet formulation and method
#631Pharmaceutical compositions
#632Dosage forms of bisphosphonates
#633Pharmaceutical compositions for the coordinated delivery of NSAIDs
#634Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
#635Modified-release tablet of bupropion hydrochloride
#636Proton pump inhibitor formulations, and methods of preparing and using such formulations
#637Enteric coatings for orally ingestible substrates
#638Method of treating amyloid beta precursor disorders
#639Coated tablet formulation and method
#640Gastrointestinal-specific multiple drug release system
#641Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
#642Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
#643Sustained release oral formulations
#644Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
#645Preparation composition containing acid-unstable physiologically active compound, and process for producing same
#646System for the controlled release of active ingredients
#647Drug delivery system for averting pharmacokinetic drug interaction and method thereof
#648Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
#649Rapidly disintegrating gelatinous coated tablets
#650Rapidly disintegrating gelatinous coated tablets
#651Systems, methods and apparatuses for manufacturing dosage forms
#652Method of treatment for improved bioavailability
#653Pharmaceutical formulations of amyloid inhibiting compounds
#654Osmotic device containing licofelone
#655Systems, methods and apparatuses for manufacturing dosage forms
#656Method and apparatus for transferring substrates
#657Method of treating attention deficit disorders with D-threo methylphenidate
#658Solid compositions containing compounds unstable to oxygen and method for stabilization thereof
#659Drug coating providing high drug loading
#660Zero order controlled drug delivery system
#661Therapeutic system for the controlled release of active ingredients
#662Modafinil modified release pharmaceutical compositions
#663Formulations and methods of treating inflammatory bowel disease
#664Controlled release drug delivery system of pravastatin
#665Oral 2-methyl-thieno-benzodiazepine formulation
#666Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
#667Chronic, bolus administration of D-threo methylphenidate
#668Pharmaceutical compositions having a swellable coating
#669Pharmaceutical compositions for rectal and vaginal administration
#670Oral pharmaceutical formulations of acid-labile active ingredients and process for making same
#671Composite dosage forms
#672Pharmaceutical preparations containing aminobenzene-sulfonic acid derivatives as the active ingredient
#673Method and apparatus for the coating of substrates for pharmaceutical use
#674Coated tablets for pH-dependent release of benzgalantamine
#675Enteric coated tiopronin tablet
#676Dose-dumping resistant controlled release dosage form
#677Dose-dumping resistant controlled release dosage form
#678Dose-dumping resistant controlled release dosage form
#679Extended release pharmaceutical formulations
#680Injectable sustained release delivery devices